Thursday, October 1, 2026
27.9 C
Bengaluru

PM-JAY – Low Hanging Fruit for Healthcare Fraud?

PM-JAY is already attracting systematic fraud and abuse, and unless safeguards keep pace with expansion, it risks becoming a prime “low‑hanging fruit” for unethical providers after retail health insurance.[1][2][3]

From retail insurance fraud to PM-JAY abuse

  • In the retail and group insurance market, familiar fraud patterns include inflated bills, unnecessary procedures, fake claims, and collusion between hospitals, patients, and intermediaries.[4][5][6]
  • PM-JAY replicates many of the same structural incentives—third‑party payment, information asymmetry, weak regulation of private hospitals—but on a much larger, government‑funded platform with politically driven enrollment and spending targets.[2][5][1]
  • The combination of high volumes, standardized package rates, and a poor, less‑empowered beneficiary base makes PM-JAY particularly attractive for organized fraud compared with traditional health insurance, where insurers have more mature fraud‑detection systems.[5][1][4]

Evidence that PM-JAY is being targeted

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Topics

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...
spot_img

Related Articles

spot_imgspot_img